Nitrosonium Cation as an Antitumor Component of Dinitrosyl Iron Complexes with Thiol-Containing Ligands

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The combination of two compounds such as the binuclear form of dinitrosyl iron complexes with glutathione (B-DNIC-G, 100 µM/kg, s/c) and sodium diethyldithiocarbamate (DETK, 500 µM/kg, i/p), administered eight times, causes two week-lasting complete inhibition of solid tumor development in mice after tumor transplantation (Lewis lung carcinoma). However, when the antitumor effect was evaluated on the 20th day after the end of drug administration, the maximum activityinhibition of tumor growth by 60% − was observed when drugs were administered in the order DETK, and then after an hour B-DNIC-G, while when drugs were used in reverse order, tumor growth inhibition was not greater than 30%. Based on the analysis of EPR measurements of tumor tissues (day 15 of tumor development), it was concluded that the inhibition of tumor growth was caused by nitrosonium cations released from B-DNIC-G during the breakdown of these complexes under the action of DETC. .

作者简介

A. Vanin

N.N. Semenov Federal Research Center of Chemical Physics

Email: vanin.dnic@gmail.com
Moscow, Russia

L. Ostrovskaya

N.M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Email: larros@list.ru
Moscow, Russia

D. Korman

N.M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Moscow, Russia

V. Rykova

N.M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Moscow, Russia

N. Bluhterova

N.M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Moscow, Russia

M. Fomina

N.M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Moscow, Russia

V. Mikoyan

N.N. Semenov Federal Research Center of Chemical Physics

Moscow, Russia

N. Tkachev

N.N. Semenov Federal Research Center of Chemical Physics

Moscow, Russia

参考

  1. Borodulin R. R., Kubrina L. N., Mikoyan V. D. Poltorakov A. P., Shvydkiy V. O., Burbaev D. Sh., Serezhenkov V. A., Yakhontova E. R., and Vanin A. F. Dinitrosyl iron complexes with glutathione as NO and NO+ donors. Nitric Oxide, 29, 4—16 (2013). doi: 10.1016/j.niox.2012.11.001
  2. Vanin A. F., Tronov V. A., and Borodulin R. R. Nitrosonium cation as a cytotoxic component of dinitrosyl iron complexes with thiol-containing ligands (based on the experimental work on MCF-7 hyman breast cancer cell culture). Cell Biochem. Biophys., 79 (1), 93-102 (2021). doi: 10.1007/s12013-020-00962-x
  3. Галаган М. Е., Орановская Е. В., Мордвинцев П. И., Медведев О. С. и Ванин А. Ф. Гипотенизивный эффект динитрозильных комплексов железа на бодрствующих животных. Бюл. Всесоюз. кардиол. центра, 2, 75-79 (1988).
  4. Ванин А.Ф., Телегина Д.И., Микоян В.Д., Ткачев Н.А., Васильева С.В. Цитостатическое действие динитрозильных комплексов железа с глутатионом на клетки Escherichia coli определяется катионами нитрозония, высвобождающимися из этих комплексов. Биофизика, 67, 938-946 (2022). doi: 10.31857/S0006302922050106
  5. Шиповалов А. В., Ванин А. Ф., Пьянков О. В., Багрянская Е. Г., Микоян В. Д. и Попкова В. Я. Противовирусная активность катионов нитрозония в отношении SARS-CoV-2 на модели сирийского хомячка. Биофизика, 67 (5), 969-981 (2022). doi: 10.31857/S0006302922050167
  6. Ванин А. Ф., Островская Л. А., Корман Д. Б., Блюхтерова Н. В., Рыкова В. А. и Фомина М. М. Роль катиона нитрозония в механизме противоопухолевого эффекта препаратов динитрозильных комплексов железа. Биофизика, 67 (5), 982-990 (2022). doi: 10.31857/S0006302922050179
  7. Borodulin R. R., Kubrina L. N., Shvydkiy V. O., Lakomkin V. L., and Vanin A. F. A simple protocol for the synthesis of dinitrosyl iron complexes with glutathione: EPR, optical, chromatographic and biological characterization of reaction products. Nitric Oxide, 35, 110-115 (2013). doi: 10.1016/j.niox.2013.08.007
  8. Vanin A. F., Poltorakov A. P., Mikoyan V. D., Kubrina L. N., and Burbaev D. S. Polynuclear water-soluble dinitrosyl iron complexes with cysteine or glutathione ligands: electron paramagnetic resonance and optical studies. Nitric Oxide, 23, 136-149 (2010). doi: 10.1016/j.niox.2010.05.285
  9. Трещалина Е. М., Жукова О. С., и Герасимова Г. К. В кн. Руководство по проведению доклинических исследований лекарственных средств. Под ред. А. Н. Миронова (Изд-во «Грин и К», 2012), ч. 1, сс. 642657.
  10. Emanuel N. M., Saprin A. N., Shabalkin V. A., Kozlova L. E., and Kruglyakova K. E. Detection and investigation of a new type of ESR signal characteristic of some tumour tissues. Nature, 222 (5189), 165-167 (1969). doi: 10.1038/222165a0
  11. Ignarro L. J. Nitric Oxide: Biology and Pharmacology (Acad. Press, San Diego, USA, 2000).
  12. Ванин А. Ф., Блюменфельд Л. А. и Четвериков А. Г. Исследование комплексов негемового железа в клетках и тканях методом ЭПР. Биофизика, 12, 829841 (1967).
  13. Ванин А. Ф. Динитрозильные комплексы железа с тиолсодержащими лигандами. Физико-химия, биология, медицина (Институт компьютерных исследований, Москва-Ижевск, 2015).
  14. Vanin A. F., Serezhenkov V. A., Mikoyan V. D., and Genkin M. V. The 2.03 signal as an indicator of dinitrosyl-iron complexes with thiol-containing ligands. Nitric Oxide, 2, 224-234 (1998). doi: 10.1006/niox.1998.0180

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russian Academy of Sciences, 2024